NCT07095179

Brief Summary

The purpose of this study is to investigate whether inspiratory muscle training has an immediate effect on energy expenditure, heart rate, blood glucose, blood pressure, and arterial stiffness in healthy adults, obese adults, and adults with type 2 diabetes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Mar 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Mar 2026Aug 2027

First Submitted

Initial submission to the registry

July 24, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

1.4 years

First QC Date

July 24, 2025

Last Update Submit

February 4, 2026

Conditions

Keywords

Energy ExpenditureMetabolic HealthPulse Wave VelocityInspiratory muscle training

Outcome Measures

Primary Outcomes (2)

  • Blood glycaemic responses

    Changes in blood glycaemic responses between trials

    0 (baseline), 30, 60, 120, and 210 minutes during the 210-minute trial

  • Pulse wave velocity (PWV)

    Changes in pulse wave velocity between trials

    0 (baseline), 30, 60, 90, 150, and 210 minutes during the 210-minute trial

Secondary Outcomes (4)

  • Energy expenditure

    First 90 minutes during the 210-minute trial

  • Heart Rate Variability (HRV)

    In a regular patterns during the 210-minute trial

  • Visual analogue scale (VAS)

    Every 30 minutes during the 210-minute trial

  • Perceived stress scale (PSS)

    Every 30 minutes during the 210-minute trial

Study Arms (2)

Eupnea

EXPERIMENTAL

Participants will breathe normally.

Behavioral: Eupnea

Inspiratory muscle training

EXPERIMENTAL

Intermittent inspiratory muscle training (IMT) will be conducted throughout the trial

Behavioral: Intermittent inspiratory muscle training (IIMT)

Interventions

EupneaBEHAVIORAL

Participants will breathe normally.

Eupnea

Intermittent inspiratory muscle training (IIMT) will be conducted throughout the trial

Inspiratory muscle training

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adults, obese adults and adults with type 2 diabetes
  • Aged between 20 to 45 years
  • Weight stable for more than 3 months (no change in weight +/- 3%)
  • Non-smoker
  • Non-highly trained athletic team members
  • Normal lifestyle patterns

You may not qualify if:

  • Personal history of/existing hypertension, respiratory infectious disease, cardiovascular disease, metabolic disease
  • Taking medications that may influence lipid or carbohydrate metabolism or immune system function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Yung-Chih Chen, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 24, 2025

First Posted

July 31, 2025

Study Start

March 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

February 6, 2026

Record last verified: 2026-02